Syngulon introduces a new genetic technology (US Patent 9,333,227 + NEW patents filed in 2017) focusing on the control of microorganisms The patent is based on the use of bacteriocin/immunity to improve microbial fermentation. Syngulon has demonstrated at lab scale the efficacy of its selection technology and is working with customers to use its selection technology for the production of recombinant products.
展开▼
